222 related articles for article (PubMed ID: 26002590)
1. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.
Costacou T; Levy AP; Miller RG; Snell-Bergeon J; Asleh R; Farbstein D; Fickley CE; Pambianco G; de la Vega R; Evans RW; Orchard TJ
Acta Diabetol; 2016 Apr; 53(2):243-50. PubMed ID: 26002590
[TBL] [Abstract][Full Text] [Related]
2. Impact of Vitamin E supplementation on vascular function in haptoglobin genotype stratified diabetes patients (EVAS Trial): a randomised controlled trial.
Dalan R; Goh LL; Lim CJ; Seneviratna A; Liew H; Seow CJ; Xia L; Chew DEK; Leow MKS; Boehm BO
Nutr Diabetes; 2020 Apr; 10(1):13. PubMed ID: 32341356
[TBL] [Abstract][Full Text] [Related]
3. Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.
Asleh R; Blum S; Kalet-Litman S; Alshiek J; Miller-Lotan R; Asaf R; Rock W; Aviram M; Milman U; Shapira C; Abassi Z; Levy AP
Diabetes; 2008 Oct; 57(10):2794-800. PubMed ID: 18599520
[TBL] [Abstract][Full Text] [Related]
4. Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype.
Asleh R; Levy AP
Antioxid Redox Signal; 2010 Feb; 12(2):209-17. PubMed ID: 19769483
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype.
Farbstein D; Blum S; Pollak M; Asaf R; Viener HL; Lache O; Asleh R; Miller-Lotan R; Barkay I; Star M; Schwartz A; Kalet-Littman S; Ozeri D; Vaya J; Tavori H; Vardi M; Laor A; Bucher SE; Anbinder Y; Moskovich D; Abbas N; Perry N; Levy Y; Levy AP
Atherosclerosis; 2011 Nov; 219(1):240-4. PubMed ID: 21722898
[TBL] [Abstract][Full Text] [Related]
6. Haptoglobin Genotype Is a Determinant of Hemoglobin Adducts and Vitamin E Content in HDL.
Goldenstein H; Levy NS; Ward J; Costacou T; Levy AP
J Diabetes Res; 2018; 2018():6125420. PubMed ID: 29888289
[TBL] [Abstract][Full Text] [Related]
7. Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.
Hochberg I; Berinstein EM; Milman U; Shapira C; Levy AP
Curr Diab Rep; 2017 Jun; 17(6):42. PubMed ID: 28451949
[TBL] [Abstract][Full Text] [Related]
8. Does the Concentration of Oxidative and Inflammatory Biomarkers Differ by Haptoglobin Genotype in Type 1 Diabetes?
Costacou T; Evans RW; Orchard TJ
Antioxid Redox Signal; 2015 Dec; 23(18):1439-44. PubMed ID: 26114833
[TBL] [Abstract][Full Text] [Related]
9. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
Dalan R; Liuh Ling G
Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
[TBL] [Abstract][Full Text] [Related]
10. Anti-oxidative treatment with vitamin E improves peripheral vascular function in patients with diabetes mellitus and Haptoglobin 2-2 genotype: A double-blinded cross-over study.
Alshiek JA; Dayan L; Asleh R; Blum S; Levy AP; Jacob G
Diabetes Res Clin Pract; 2017 Sep; 131():200-207. PubMed ID: 28759833
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E supplementation improves high-densitiy lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis
.
Mune M; Uto-Kondo H; Iteya I; Fujii Y; Ikeda S; Ikewaki K
Clin Nephrol; 2018 Sep; 90(3):212-221. PubMed ID: 29628022
[TBL] [Abstract][Full Text] [Related]
13. [Effect of vitamin E supplementation on the vitamin content of lipoprotein in young men and women].
Somogyi A; Herold M; Kocsis I; Nagy G; Somfai G; Studinger P
Orv Hetil; 2005 Aug; 146(35):1813-8. PubMed ID: 16187540
[TBL] [Abstract][Full Text] [Related]
14. Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of alpha-tocopherol supplementation.
Sampson MJ; Astley S; Richardson T; Willis G; Davies IR; Hughes DA; Southon S
Clin Sci (Lond); 2001 Sep; 101(3):235-41. PubMed ID: 11524040
[TBL] [Abstract][Full Text] [Related]
15. The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.
Levy AP; Friedenberg P; Lotan R; Ouyang P; Tripputi M; Higginson L; Cobb FR; Tardif JC; Bittner V; Howard BV
Diabetes Care; 2004 Apr; 27(4):925-30. PubMed ID: 15047650
[TBL] [Abstract][Full Text] [Related]
16. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
[TBL] [Abstract][Full Text] [Related]
17. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.
Costacou T; Orchard TJ
J Diabetes Complications; 2016 Mar; 30(2):221-6. PubMed ID: 26684170
[TBL] [Abstract][Full Text] [Related]
18. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.
Veiner HL; Gorbatov R; Vardi M; Doros G; Miller-Lotan R; Zohar Y; Sabo E; Asleh R; Levy NS; Goldfarb LJ; Berk TA; Haas T; Shalom H; Suss-Toby E; Kam A; Kaplan M; Tamir R; Ziskind A; Levy AP
Atherosclerosis; 2015 Mar; 239(1):232-9. PubMed ID: 25618031
[TBL] [Abstract][Full Text] [Related]
20. Haptoglobin Phenotype Is Associated With High-Density Lipoprotein-Bound Hemoglobin Content and Coronary Endothelial Dysfunction in Patients With Mild Nonobstructive Coronary Artery Disease.
Asleh R; Levy AP; Levy NS; Asleh A; Goldenstein H; Segol I; Gulati R; Lerman LO; Lerman A
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):774-786. PubMed ID: 30727751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
